TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015

Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial.

Harry Raftopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.